casemark/analyzing-public-to-private-transactions

Analyzing Public To Private Transactions

When To Use

• Evaluating whether a publicly traded company is a viable take-private candidate
• Modeling go-private premiums and assessing implied returns at various offer prices
• Analyzing financing capacity (debt quantum, equity check size) for a leveraged take-private
• Reviewing governance mechanics — board composition, shareholder approval thresholds, anti-takeover provisions
• Assessing regulatory filing requirements and timeline risk for transaction closing

Inputs To Gather

• Target company financials: Last 3 years of audited financials plus LTM; current trading data (share price, volume, market cap, enterprise value)
• Capital structure: Outstanding shares (basic and fully diluted), convertible instruments, existing debt with change-of-control provisions
• Governance documents: Charter, bylaws, shareholder rights plan (poison pill), staggered board provisions, supermajority requirements
• Shareholder register: Top 20 holders, activist positions, insider ownership percentage, short interest
• Comparable transactions: Recent public-to-private deals in same sector with premium and multiple data
• Financing market context: Current leveraged loan and high-yield spreads, lender appetite for sector, available stapled financing terms
• Regulatory profile: Industry-specific approvals needed (HSR, CFIUS, sector regulators), jurisdictional requirements [VERIFY]

Workflow

1. Establish baseline valuation

   • Calculate unaffected share price (use 30-day VWAP prior to any leak or rumor date)
   • Build DCF, comparable company, and precedent transaction valuations
   • Identify valuation disconnect — is the company trading below intrinsic value, and why (market dislocation, orphaned coverage, misunderstood story)?

2. Model go-private premium range

   • Analyze premiums paid in comparable take-privates (1-day, 30-day, 60-day premia)
   • Bracket offer price range: minimum to clear appraisal risk vs. maximum to meet return hurdle
   • Sensitivity table: offer price vs. sponsor IRR at varying leverage levels and exit multiples

3. Assess financing capacity

   • Determine maximum debt quantum using sector-appropriate leverage benchmarks (Senior / Total leverage, interest coverage, fixed charge coverage)
   • Size the equity check and test against fund concentration limits and co-invest appetite
   • Identify rollover equity participants (management, founders, strategic holders)
   • Stress-test the capital structure against downside operating scenarios

4. Evaluate governance and deal mechanics

   • Map approval path: one-step merger vs. two-step tender offer; simple majority vs. supermajority vote [VERIFY — depends on state of incorporation]
   • Identify anti-takeover defenses: poison pill, staggered board, no-shop / go-shop provisions likely in merger agreement
   • Assess special committee process requirements (particularly if management is part of the buyer group)
   • Flag MFW (Kahn v. M&F Worldwide) compliance for controller-led take-privates [VERIFY — Delaware law specific]

5. Map regulatory and timeline risk

   • HSR filing: determine if thresholds are met, estimate review timeline, identify potential second-request risk areas [VERIFY — current HSR thresholds]
   • CFIUS: assess whether foreign ownership or sensitive-sector issues trigger mandatory or voluntary filing
   • Sector-specific approvals: insurance, banking, telecom, defense — identify long-lead approvals early
   • SEC requirements: Schedule TO (tender offer) or proxy statement / Schedule 13E-3 (going-private transaction)
   • Build critical-path timeline from signing to closing

6. Synthesize feasibility assessment

   • Summarize go / no-go factors across valuation, financing, governance, and regulatory dimensions
   • Identify key risks and mitigants for each
   • Recommend next steps: pursue, pass, or pursue-with-conditions

Output

Structure the deliverable as follows:

• Executive summary: One-page verdict with key metrics (offer price range, implied premium, equity check, target IRR, timeline estimate)
• Valuation analysis: Unaffected price, DCF range, comps range, precedent premium analysis
• Premium and returns sensitivity: Matrix of offer price vs. IRR at 3-5 leverage and exit scenarios
• Financing assessment: Debt capacity analysis, sources-and-uses table, credit metric summary
• Governance and process: Approval mechanics, anti-takeover provisions, special committee considerations
• Regulatory and timeline: Filing requirements, estimated review periods, critical-path Gantt
• Risk matrix: Top 10 risks ranked by likelihood and impact with proposed mitigants

Quality Checks

• Confirm unaffected share price date is genuinely pre-leak — check for unusual trading volume or price movement in prior weeks
• Verify fully diluted share count includes all in-the-money options, RSUs, convertibles at the proposed offer price
• Ensure leverage multiples use consistent EBITDA definition (check for add-backs, run-rate adjustments)
• Cross-check premium statistics against a reliable precedent transaction database, not stale or cherry-picked comps
• Validate that governance analysis reflects the target's actual state of incorporation, not assumed Delaware defaults [VERIFY]
• Confirm HSR thresholds and CFIUS rules against current-year values — these adjust annually [VERIFY]
• Flag any change-of-control triggers in the target's material contracts (credit agreements, customer contracts, IP licenses) that could affect deal value